Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Urol Oncol. 2016 Jul 2;34(10):430.e1–430.e7. doi: 10.1016/j.urolonc.2016.04.015

Table 3.

Incidence of Specific Acute Grade≥ 2 GU Toxicities by Trial

RTOG 94-08
(Intact Prostate)
(n=104)		 RTOG 96-01
(Post-Prostectomy)
(n=371)		 P-Value
Acute Grade 0–1 GU Toxicity 72 (69.2%) 319 (86.0%) 0.0076
Acute Grade ≥ 2 GU Toxicity 32 (30.8%) 52 (14.0%)
 UTI 0 (0.0%) 1 (0.3%)
 Dysuria 4 (3.8%) 5 (1.4%)
 Frequency 10 (9.6%) 13 (3.5%)
 frequency/dysuria 0 (0.0%) 2 (0.6%)
 hematuria/catheter placement 0 (0.0%) 1 (0.3%)
 hematuria/dysuria 0 (0.0%) 1 (0.3%)
 Hesitancy 0 (0. 0%) 1 (0.3%)
 Incontinence 0 (0.0%) 1 (0.3%)
 not specified 17 (16.4%) 26 (7.0%)
 obstruction–catheter needed 1 (1.0%) 0 (0.0%)
 retention w/catheter placement 0 (0.0%) 1 (0.3%)